HomeNewsGlobal Pharma

SSI Strategy to Leverage Metalmind AI Solutions to Enhance its Service Offerings

SSI Strategy to Leverage Metalmind AI Solutions to Enhance its Service Offerings

SSI Strategy has collaborated with MPS Metalmind AB, an innovator in AI services.

This collaboration marks a significant milestone for SSI Strategy, emphasizing its commitment to leveraging cutting-edge artificial intelligence to drive innovation and enhance business capabilities.

Through this partnership, SSI Strategy will leverage Metalmind’s advanced capabilities in natural language processing (NLP) and large language models (LLMs) to enhance SSI’s service delivery.

Johan Strömquist, Chief Innovation Officer at SSI Strategy said, “Partnering with Metalmind opens new possibilities for SSI Strategy, enhancing our service offerings and strengthening our market position. This collaboration positions SSI Strategy as a leader in AI-supported consulting services and allows us to scale to meet growing client demands without compromising quality.”

SSI Strategy is a global strategic consulting firm dedicated to supporting the medical office needs of life science organizations. Headquartered in Parsippany, NJ, SSI Strategy helps clients maximize therapeutic value from translational development to product launch, expertly navigating the complexities of bringing important therapeutics to market.

More news about: global pharma | Published by Aishwarya | July - 31 - 2024 | 224

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members